Related Experiment Video
Updated: Jul 22, 2025

06:51
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
7.7K
Novel Vectors and Administrations for mRNA Delivery.
Chenghai Bai1,2, Chen Wang1,2, Yuan Lu1,2
1Key Laboratory of Industrial Biocatalysis, Ministry of Education, Tsinghua University, Beijing, 100084, China.
Small (Weinheim an Der Bergstrasse, Germany)
|July 21, 2023
Summary
Novel vectors like biomacromolecules and inorganic nanoparticles improve messenger RNA (mRNA) delivery. These advanced strategies enhance safety and efficiency for mRNA therapies, overcoming limitations of traditional methods.
Area of Science:
- Biotechnology
- Molecular Biology
- Nanomedicine
Background:
- Messenger RNA (mRNA) holds significant therapeutic potential across various fields.
- Challenges in mRNA therapy include cell membrane penetration and RNase degradation.
- Conventional vectors (viruses, liposomes) face limitations in safety, efficiency, and targeting.
Purpose of the Study:
- To review novel vectors for mRNA delivery.
- To explore advanced administration methods for mRNA therapies.
- To address challenges in current mRNA delivery systems.
Main Methods:
- Categorization of novel vectors into biomacromolecules and inorganic nanoparticles.
- Introduction of controlled-release and non-invasive administration strategies.
- Analysis of vector and administration characteristics for problem-solving.
Main Results:
- Novel vectors offer enhanced safety, biocompatibility, versatility, intelligence, and targeting.
- Advanced administration methods provide improved control and non-invasive delivery options.
- These strategies address key limitations of traditional mRNA delivery.
Conclusions:
- Novel biomacromolecular and inorganic nanoparticle vectors are crucial for effective mRNA delivery.
- Controlled-release and non-invasive administration enhance therapeutic outcomes.
- Future mRNA therapies will benefit from these innovative delivery strategies.

